您当前的位置:首页 > 核医学

脑动脉溶栓术后合并应用参附注射液神经保护作用的研究

时间:2006-05-19 19:14:21  来源:  作者:

The Neuroprotective Effect of ShenFu Injection(SF) on Patients Undergoing Intra-arterial Thrombolysis(IAT) after Cerebral Stroke<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />

刘怀军 贾秀川 刘增品 汪国石 李林芳

河北医科大学第二医院放射科,石家庄 050000

Huai-jun Liu,Zeng-pin Liu,Xiu-chuan Jia,Guo-shi Wang,Lin-fang Li

Department of Radiology,the Second Affiliated Hospital of Hebei Medical University,Shijia zhuang 050000,China

 

ABSTRACT

Objective:To assess the neuroprotective effect of ShenFu injection(SF) on patients undergoing intra-arterial thrombolysis(IAT) after cerebral stroke.

Methods:45 patients within 6h of acute ischemic stroke onset were treated with IAT.30 patients with complete/partial recanalization were divided into SF treated group and control group randomly.The NIHSS scores before IAT were compared with that after IAT.The NIHSS scores and Modified Rankin Scale(MRS) scores after 3 months were evaluated between two groups.

Results:There are statistic significance in NIHSS scores between two groups after IAT.The Modified Rankin Scale(MRS) scores of SF treated group after 3 months was significantly better than that of control group.

Conclusion:There is definite neuroprotective effect of SF injection in combined use with IAT after cerebral ischemic stroke.Combining thrombolytics with neuroprotective strategies shows great promise and a bright future for cerebrovascular disease.

Key words:intra-arterial thrombolysis(IAT);reperfusion injury;ShenFu injection;neuroprotective agent

来顶一下
返回首页
返回首页
 
推荐资讯
掌间筑未来,西门子医疗推出全新CT产品SOMATOM go.
掌间筑未来,西门子医疗
“智”动创新 共享“健康中国” 西门子医疗亮相2017 HOSPEQ
“智”动创新 共享“
西门子医疗携一系列创新成果亮相CMEF 2017   助力“智慧”医疗服务建设
西门子医疗携一系列创
西门子医疗中国亮相第77届中国国际医疗器械春季博览会,多方位展示互联网时代下 “智慧”成果
西门子医疗中国亮相第
最后更新
热门点击
  1. 21世纪核医学需要什么样的技术人员?
  2. 渗透压对对比剂肾病发生率的影响:有关在高
  3. 核医学技师出路在何方?对核医学技术人员队伍
  4. PET-CT在肾上腺肿瘤诊断中的诊断效能和判读
  5. 核医学:传统经典的新兴学科
  6. 冠状动脉造影、心电图、核素检查对冠心病诊
  7. 核医学检查对人体有伤害吗?
  8. 《走进核医学》教学录相片的制作
  9. 高分辨率 MRI 可确诊大脑前动脉夹层
  10. 内皮抑素基因联合放射治疗对大鼠Walker-256